Skip To Main Content

Polyp Gossip – Episode 8

Can remission become the new benchmark in CRSwNP care? In this episode, our expert panel explores the evolving treatment landscape and what "remission" truly means for patients and clinicians. Join us as we look ahead to a future beyond symptom control - where long-term outcomes and deeper disease understanding could transform the way we define treatment success.

PREVIOUS EPISODE

Polyp Gossip Episode 8: The Future of CRSwNP Treatment: Aiming for remission

Can remission become the new benchmark in CRSwNP care? In this episode, our expert panel explores the evolving treatment landscape and what "remission" truly means for patients and clinicians. Join us as we look ahead to a future beyond symptom control - where long-term outcomes and deeper disease understanding could transform the way we define treatment success.

Expert panel

Peters-Anju
StellaLee
Peter Hellings

Previous episodes

Biography

Peter Hellings

Peter W. Hellings, MD, PhD, is a Professor and Clinic Head at the Department of Otorhinolaryngology at the University Hospitals of Leuven, and a Guest Professor at Ghent University, Belgium.

Prof. Hellings' research has led to novel insights into the pathophysiology of allergy and chronic airway inflammation, with over 350 scientific publications in top journals in the field of allergology, rhinology, and respiratory care. He is the founder of the European Forum for Research and Education in Allergy and Airway Diseases, an international nonprofit involving a consortium of European key opinion leaders aiming at the implementation of optimal care for chronic respiratory diseases. He is also the founder and director of the European Rhinoplasty Course and a member of European and American guideline committees.

Other channels to subscribe

POLLYP_GOSSIP

Don’t miss the next episode, go to your favorite player and subscribe to the podcast

Voit olla kiinnostunut myös näistä

MAT-BE-2400965 V1.0 OCTOBER 2024